News Ex-Allergan CEO Saunders pops up again in ‘blank cheque’ com... Brent Saunders has been out of the limelight for a few months since departing Allerg
News Discontent at Allergan over CEO's chairman role - report There is discontent among Allergan’s shareholders over CEO Brent Saunders’ dual role as chairman, according to press reports.
News Petition to block Trump state visit to UK grows to 1.6 milli... Biotech leaders speak out, but pharma largely silent
News Orchard's gene therapy for MLD finally gets US approval The FDA has cleared its first gene therapy for kids with metachromatic leukodystrophy (MLD), a rare genetic disorder of the brain and nervous centre.
Sales & Marketing Sponsored Take pharma brand planning to the next level in 2024 Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment